Click Here to return To Results

 

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016 See this aricle in Pubmed Article Abstract Rituximab is effective and safe as a second-line immunotherapy for ALE, regardless of autoantibody status. Additional monthly rituximab therapy might potentiate the efficacy of rituximab.

Related Tags

(click to filter results - removes previous filter) efficacy encephalitis,autoimmune immunotherapy limbic encephalitis monoclonal antibodies rituximab safety treatment of neurologic disorder

Click Here to return To Results